AI brief
OpenAI Group PBC acquired Orchestra Bio Inc., a startup that builds AI agents to help pharmaceutical teams keep drug development programs on track. Orchestra's staff and technology will now sit within OpenAI.
Written by AI from SiliconANGLE AI's published text.
Background
From our own funding, model and news trackers, not from the source.
OpenAI
- Latest funding
- $30B · 31 Oct 2026
- Newest model on the API
- GPT-6.1 Terra Pro · 26 Oct 2026 · $1 in / $5 out per million tokens
Source
“OpenAI Group PBC revealed today that it has acquired drug development software startup Orchestra Bio Inc. Orchestra builds artificial intelligence agents that help pharmaceutical teams keep development programs on track,.”
Reporting from a publisher outside the organisation being covered.
Read original story ↗